935
Views
8
CrossRef citations to date
0
Altmetric
Article Commentary

Impervious to Randomness: Confounding and Selection Biases in Randomized Clinical Trials

ORCID Icon
Pages 783-788 | Received 05 Aug 2021, Accepted 24 Aug 2021, Published online: 13 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Pavlos Msaouel. (2023) Less is More? First Impressions From COSMIC-313. Cancer Investigation 41:1, pages 101-106.
Read now
Pavlos Msaouel. (2022) The Big Data Paradox in Clinical Practice. Cancer Investigation 40:7, pages 567-576.
Read now
Vicente Valentí, Paula Jiménez-Fonseca, Pavlos Msaouel, Ramón Salazar & Alberto Carmona-Bayonas. (2022) Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit. Cancer Investigation 40:2, pages 184-188.
Read now
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Javier Gallego & Pavlos Msaouel. (2022) Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries. Cancer Investigation 40:1, pages 1-13.
Read now

Articles from other publishers (3)

Pavlos Msaouel, Juhee Lee, Jose A. Karam & Peter F. Thall. (2022) A Causal Framework for Making Individualized Treatment Decisions in Oncology. Cancers 14:16, pages 3923.
Crossref
P. Jimenez-Fonseca, R. Salazar, V. Valenti, P. Msaouel & A. Carmona-Bayonas. (2022) Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial. Annals of Oncology 33:8, pages 786-793.
Crossref
Andrew W. Hahn, Nazli Dizman & Pavlos Msaouel. (2022) Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive. Therapeutic Advances in Medical Oncology 14, pages 175883592211031.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.